Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy Needham & Company LLC

Galmed Pharmaceuticals Ltd.
Start price
€6.40
25.02.26 / 50%
Target price
€96.72
25.02.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 25.02.27. The prediction end date can be changed by Needham___Company_LL at any time.
Performance without dividends (%)
Name 1w 1m
Galmed Pharmaceuticals Ltd. - -
iShares Core DAX® 3.075% 0.488%
iShares Nasdaq 100 2.876% 0.081%
iShares Nikkei 225® 5.981% 3.033%
iShares S&P 500 2.231% 0.046%

Comments by Needham___Company_LL for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) -
Target price 96.718
Change
Ends at 25.02.27

Globus Medical (GMED) had its price target raised by Needham & Company LLC from $112.00 to $114.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat

Needham & Company LLC 
0
Report Share
25.02.26